You are receiving this e-mail because you subscribed to The Daily Health on 2010-06-04 00:00:00

If you have not already done so, please confirm your subscription here.

Click the link if you'd like to unsubscribe from The Daily Health

DAILY HEALTH RECOMMENDS 63 BREAKTHROUGH Arthritis Solutions ...Your doctor won't tell you about this! .. A groundbreaking research report that will help you put an end to your arthritis pain... .. STOP suffering from Arthritis pain today Order your report here and enjoy a privileged one-time-only 50% discount on the full price. START FEELING YOUNGER, RIGHT NOW with our special FREE offer... youthful, vibrant good health IS achievable - it really exists, if you're willing to ignore the mainstream... Find out here about 139 sure-fire ways to look and feel fabulous whatever your age! At last! Powerful pain-relief treatment, 'shrunk down' to the size of a pocket torch… Reduces pain from "intense, distressing or excruciating" . . . to "mild or none" for 89.9% of users ! Here's how you, too, can pulse pain away... In Today's Issue 14 June 2010 BIOMEDICAL BREAKTHROUGH: Restoring sexual function in 81.1% of men Prostate cancer drug risks heart failure and sexual dysfunction Get natural infection protection all year round BIOMEDICAL BREAKTHROUGH: Restoring sexual function in 81.1% of men - regardless of their age! ** Stay Firm Naturally, for Longer: End your bedroom disappointment WITHOUT risking your health ** Love Better: Nobel Prize-winning breakthrough can help Save your manhood - and your heart! ** Put the Passion Back in Your Relationship: Turn back the clock 10, 15 or even 20 years on your sexual performance Click here to read the full private and confidential report. Prostate Cancer Drug Risks Heart Failure and Sexual Dysfunction Dear Reader, Men, if your doctor recommends a drug called Avodart (dutasteride) to help lower your risk of prostate cancer, he's going to offer some evidence that might seem convincing. What's the rush Avodart is designed to treat enlarged prostate (also known as BPH, or benign prostatic hyperplasia). In a recent New England Journal of Medicine (NEJM) study, about 3,300 men at high risk of prostate cancer took Avodart for four years. About 3,420 men — also at high risk — took a placebo. Compared to placebo, the relative risk of any level of prostate cancer was reduced by nearly 23 per cent in the Avodart group. So based purely on that number, your doctor might encourage you to take Avodart if you're at high risk of prostate cancer. And keep in mind that every man between the ages of 50 and 75 is considered high risk. But let's look a little deeper before you fill that prescription... * In years one through four, nearly all subjects underwent a needle biopsy * Among 3,299 men in the Avodart group, 220 tumours were detected with moderate to high Gleason scores (the system that rates the aggressiveness of tumours). * Among 3,407 men in the placebo group, 233 tumours were detected with moderate to high Gleason scores. * During years three and four, 12 tumours with high Gleason scores were discovered in the Avodart group, but only one in the placebo group. So when it comes to aggressive tumours, Avodart doesn't appear to reduce risk at all. And then there were the side effects: Sexual dysfunction was significantly higher in the Avodart group, and — even more important to know — subjects in that group were nearly twice as likely to experience heart failure compared to placebo. The doctor will see you now... At this point, any man who's still on the fence about using this expensive drug to prevent prostate cancer should consider a second opinion from an experienced urologist. Someone like Dr. Patrick Walsh. Dr. Walsh is currently a Distinguished Service Professor of Urology at Baltimore's Johns Hopkins School of Medicine, in the US, where he served as Urologist-in-Chief for 30 years. In other words, when it comes to man-plumbing, Dr. Walsh knows his stuff. An editorial by Dr. Walsh appears in the same NEJM issue as the Avodart study. And to get the full gist, you'll need to know that "dutasteride" is the generic name for Avodart, and "finasteride" is the generic name for Proscar, another popular BPH drug. Shrinking violet Dr. Walsh: "Dutasteride and finasteride do not prevent prostate cancer but merely temporarily shrink tumours that have a low potential for being lethal, and they do not reduce the risk of a positive biopsy in patients who have an elevated PSA level." And just last year, in the journal Prostate Cancer Discovery, Dr. Walsh had this to say about finasteride: "Men will believe that it prevents cancer, will be pleased that their PSA levels fall, and will not understand the potential danger they're in — of undiagnosed high-grade disease." In a recent interview with, Dr. Walsh said his 2009 comments about finasteride also apply to dutasteride. Speaking specifically about the Avodart study, he said the results showed, "there was a 23 per cent reduction in low- grade tumours that the patients would never have known they had. Does this sound like an indication to take a pill with sexual side effects that costs $4 a day?" If Dr. Walsh is unimpressed with the Avodart study results, there's no reason you or your doctor should be impressed. Continues below... *Highly Recommended* Get Natural Infection Protection All Year Round Kick-start your body's natural immunity and stay free from infectious invaders? PLUS Help your body fight abnormal cell growth, and the aging process itself… AND Eliminate any fear that may drive you to the point of getting a dangerous jab this winter. Discover how you can bolster your body's own arsenal of defence against flu, superbugs and hundreds of other bacteria and viruses. Read the full report on this amazing immune booster here: ...and another thing I wonder if Christie Aschwanden's e-mail inbox suddenly filled up a few days ago. You may recall Christie's name from a previous e-Alert. I took her to task for writing an article that brimmed with ridiculous arguments against dietary supplement use, and multivitamin use in particular. She compared belief in the value of multivitamins to belief in the tooth fairy. Well...then leave a fiver under my pillow because the tooth fairy is in business. A new study, presented at the annual meeting of the American Association for Cancer Research, shows that multivitamin use may cut breast cancer risk by more than 30 per cent. Other results of the study: * Use of calcium supplements was linked to a 40 per cent reduced risk in breast cancer * Use of vitamin A, C, and E supplements were linked to slightly lower breast cancer risk * Researchers say their results suggest that vitamin supplements are more effective at supporting cancer prevention when taken together rather than individually You've got to wonder how many people saw that study and forwarded it to Christie. I hope it was a LOT! More importantly, we can only hope that ALL her readers saw these results too! To Your Good Health, Jenny Thompson HSI Director P.S. This month's Health Sciences Institute (HSI) newsletter will tell you about the all-natural formula set to succeed against infections where antibiotics have failed. You'll also discover how to give yourself a 74 per cent chance of survival from sudden cardiac arrest. Plus we'll give you full details on how a substance found in broccoli could revolutionise the way we tackle cancer. All new members who sign up to the Health Sciences Institute will receive the latest issue of HSI along with a FREE encyclopaedia, HSI's 100 Greatest Underground Cures... Soon you'll discover why our premium members believe HSI is the ultimate resource for anyone seeking a better, newer solution to their health problems. Click here for full details. Sources: "Effect of Dutasteride on the Risk of Prostate Cancer" New England Journal of Medicine, Vol. 362, No. 13, 4/1/10, content.nejm.org "Dutasteride Results Reignite Debate about Prevention of Prostate Cancer" Zosia Chustecka, Medscape, 3/31/10, medscape.com "Finasteride: Are the Risks Worth it?" Prostate Cancer Discovery, Vol. 5, Winter 2009, urology.jhu.edu "Multivitamins May Cut Breast Cancer Risk" Charlene Laino, WebMD Health News, 4/19/10, webmd.com Customer reference number: 000052221104 You are receiving this email because you have given us permission to contact you. Agora Health Ltd presents information and research which is believed to be reliable, but its accuracy cannot be guaranteed. All material in this email alert is provided for information only and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this email alert; instead readers should consult their family doctor and other qualified health professionals on any matter relating to their health and well-being. The information and opinions provided in this email alert are believed to be accurate and sound, based on the best judgement available to the authors. Readers who fail to consult with appropriate health authorities assume the risk of any injuries. The publisher is not responsible for errors or omissions. Want more? Visit The Healthier Life website. To get the very latest breakthrough treatments that are achieving remarkable success To share your views with our online community or ask a question in our Health Forum Query? Please do not reply to this email. Messages to the HSI sending address will not be seen by customer services. All correspondence should be sent to dailyhealth@agorapub.co.uk Thank you for all your emails which have been flooding in. Here at Agora Health Ltd we aim to answer as many of your queries as possible. However, due to the sheer volume of queries we are now receiving each day we cannot guarantee an individual answer to every query. For this reason we will aim to address your queries and health concerns through the e-alert itself rather than individually. Know someone who'd love to receive the HSI e-alert themselves? Know someone who'd like to receive HSI Daily Health E-alert themselves? Simply forward the following link to anyone you think could benefit from our free daily service: http://signup.agorapub.co.uk/HL/dh.html?newsourcecode2=XHDHD702 To end your subscription please click here If you do not wish to click on the unsubscribe link, please call our Customer Services department, and one of our representatives will be happy to unsubscribe you. The number to call is 0207 633 3655 between 9.00am-5.30pm, Monday to Friday. thehealthierlife.co.uk | Health Archives | Health Forum | Whitelisting Copyright 2010. All Rights Reserved. The content of this site may not be redistributed in any way with out written consent of Agora Inc.